Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-19-000432
Filing Date
2019-11-13
Accepted
2019-11-13 21:06:16
Documents
1
Period of Report
2019-11-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6718
  Complete submission text file 0001192482-19-000432.txt   9006
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Reporting) CIK: 0001396814 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39130 | Film No.: 191216024
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 484-320-2930
TELA Bio, Inc. (Issuer) CIK: 0001561921 (see all company filings)

EIN.: 455320061 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O TELA BIO, INC. 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address
Ellis Ronald J. Jr. (Reporting) CIK: 0001790670 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39130 | Film No.: 191216023